NewcelX Ltd.
Data quality: 83%
NCEL
Nasdaq
Manufacturing
Chemicals
$2.10
▼
$0.03
(-1.41%)
Mkt Cap: 9.57 M
Price
$2.10
Mkt Cap
9.57 M
Day Range
$2.06 — $2.12
52-Week Range
$1.83 — $30.80
Volume
8,919
Open $2.12
50D / 200D Avg
$2.64
20.38% below
50D / 200D Avg
$11.34
81.49% below
Quick Summary
Key Takeaways
Negative free cash flow of -4.82 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current RatioN/A
Interest Coverage-131.47
Valuation
PE (TTM)
-4.42
Below sector avg (-1.48)
P/B Ratio3.32
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -4.4 | -1.5 |
| P/B | 3.3 | 1.6 |
| ROE % | — | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -2.17 M |
| ROE | N/A | ROA | -78.31% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -4.82 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | -131.47 | Asset Turnover | N/A |
| Working Capital | N/A | Tangible Book Value | 2.88 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4.42 | Forward P/E | N/A |
| P/B Ratio | 3.32 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -50.30% | ||
| Market Cap | 9.57 M | Enterprise Value | 6.50 M |
| Per Share | |||
| EPS (Diluted TTM) | -1.74 | Revenue / Share | N/A |
| FCF / Share | -1.06 | OCF / Share | -1.06 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 222.34% |
| SBC-Adj. FCF | -4.92 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -1.98 M | -12.17 M | -16.50 M | -11.95 M | -2.86 M |
| EPS (Diluted) | -2.63 | -0.32 | -0.84 | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -4.38 M | -11.81 M | -15.48 M | -11.86 M | -2.30 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 422,051.0 | 5.91 M | 8.98 M | 5.92 M | 99,580.0 |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 45,054.0 | 119,920.0 | 95,211.0 | 48,100.0 | 86,792.0 |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 2.23 M | 1.85 M | 9.28 M | 5.76 M | 1.21 M |
| Total Liabilities | 826,764.0 | 10.68 M | 6.00 M | 5.22 M | 10.20 M |
| Shareholders' Equity | 1.41 M | -8.83 M | 3.28 M | 542,388.0 | -8.98 M |
| Total Debt | — | — | — | 113,130.0 | 113,130.0 |
| Cash & Equivalents | 1.67 M | 897,680.0 | 8.95 M | 5.43 M | 93,711.0 |
| Current Assets | 2.23 M | 1.82 M | 9.25 M | 5.72 M | 196,711.0 |
| Current Liabilities | 826,764.0 | 7.92 M | 3.36 M | 2.40 M | 7.20 M |
{"event":"ticker_viewed","properties":{"ticker":"NCEL","listing_kind":"stock","pathname":"/stocks/ncel","exchange":"Nasdaq","country":"US"}}